Webinar: Pathways to ISPOR Leadership
Tune in to the next installment of our leadership development series “Pathways to ISPOR Leadership” with special guest Mike Drummond, [...]
Department of Veterans Affairs Paid About Half as Much as Medicare Part D for Selected Drugs in 2017
A new analysis from the US Government Accountability Office shows that, in 2017, the Department of Veterans Affairs paid prescription drug prices [...]
Fierce JPM Week Partner Content Hub
This is a different approach to enabling our partners to share solutions and stories with you in a virtual environment. [...]
New Book Release by RJG Arnold: Pharmacoeconomics: From Theory to Practice
An understanding of the basic principles of pharmacoeconomics is essential if stakeholders in the healthcare arena hope to meet the [...]
New Data Show Retail Medicine Prices Fell in 2019
In 2019, retail prescription medicine prices declined by 0.4%, on average, according to National Health Expenditures (NHE) data from the Centers for Medicare & [...]
Pandemic Propels Health Systems to Mull Acquisitions, Partnerships
Nearly a year after the first confirmed case of COVID-19 in the U.S., some of the nation's largest health systems [...]
Gaps in Health Data are Barrier to Health Equity
COVID-19 has laid bare racial disparities in the United States health system. For example, COVID-19 cases among Native Hawaiian / [...]
Cerner Aspires to Build $1B Data Business in Pharma Market
Building on its acquisition of clinical research company Kantar Health, health IT giant Cerner is setting its sights on building [...]
[Podcast] Creating an HEOR Function Within Medical Affairs
In this episode of the MAPS Elevate podcast series, we explore Health Economics and Outcomes Research (HEOR), looking at why [...]
Implications of Price Transparency for Providers and Patients as New Rules Go into Effect
A new KFF analysis examines how new federal rules on price transparency for health services may affect patient decision-making and [...]
STaRT-RWE: Structured Template for Planning and Reporting on the Implementation of Real World Evidence Studies
In alignment with the International Council of Harmonization’s strategic goals, a public-private consortium has developed a structured template for planning [...]
Disparities in the Wage‑and‑Salary Earnings of HEOR Professionals
Using self-reported survey data collected in 2017 from a subset of HE/OR/MA professionals in the HealthEconomics.com global subscriber list, researchers [...]
2021 ARM – Call for Abstracts
Present your work at the premier forum for health services researchers, policy analysts, clinicians and community leaders using evidence and [...]
Specialty Generics Face Perverse Incentives In Medicare Part D
Whether specialty generics are cheaper to payers than their originator branded counterparts is partly a function of the level of [...]
Guest Blog Posts for the Journal of HEOR Website
The Journal of Health Economics and Outcomes Research is currently in the process of soliciting guest blog posts for the [...]
Race Rarely at Top of Patient’s Medical Record
Even though differences in health outcomes between Black and white people are well-established, a small survey finds that patients' race is not [...]
Drugmakers Raise Prices 3.3% in the New Year
This month pharmaceutical companies have increased list prices on hundreds of branded drugs -- mostly between 2-7% (with only a [...]
ICER Identifies Most Significant 2019 US Drug-Price Hikes
The Institute for Clinical and Economic Review (ICER) today published its latest report on Unsupported Price Increases (UPI) of prescription [...]
EQRx Scales Disruptive Model of Important New Medicines
EQRx, a company committed to developing and delivering important new medicines at lower prices, today announced that it has raised [...]
[On-demand Webinar] Avalere 2021 Healthcare Industry Outlook
The accelerated changes and increased uncertainties in healthcare brought on by the COVID-19 pandemic will continue into 2021, and its [...]
Fishawack Health Acquires The Hive Health Group
Fishawack Health (Fishawack) is a leading global commercialization partner for the modern life sciences era. The company’s three core operating units—Commercial, [...]
Virtual ISPOR 2021 Abstracts Due & Reviewers Needed!
Virtual ISPOR 2021 offers you an opportunity to present your research virtually to the leading global conference for health economics [...]
The 5 Numbers That Will Define Healthcare Value in 2021
Real world studies of COVID-19’s impact on health care utilization are arriving daily and their continued publication throughout the next [...]
Seniors Face Crushing Drug Costs as Congress Stalls on Capping Medicare Out-Of-Pockets
Unlike private health insurance, Medicare Part D drug plans have no cap on patients’ 5% coinsurance costs once they hit [...]
Read Up On How Regulators Are Using RWE
RWE is playing a growing role in FDA approvals. According to an Aetion analysis, 49 percent of submissions for new drugs [...]